Grandfield & Dodd, LLC Ionis Pharmaceuticals Inc Transaction History
Grandfield & Dodd, LLC
- $1.58 Billion
- Q3 2024
A detailed history of Grandfield & Dodd, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Grandfield & Dodd, LLC holds 34,813 shares of IONS stock, worth $1.31 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
34,813
Previous 34,053
2.23%
Holding current value
$1.31 Million
Previous $1.62 Million
14.06%
% of portfolio
0.09%
Previous 0.11%
Shares
29 transactions
Others Institutions Holding IONS
# of Institutions
403Shares Held
136MCall Options Held
862KPut Options Held
582K-
Vanguard Group Inc Valley Forge, PA15.1MShares$567 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$534 Million0.34% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$389 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.74MShares$329 Million0.06% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$297 Million5.32% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.35B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...